Quality of Life Research Initiative
The Leukemia & Lymphoma Society (LLS) recognizes the increasing need for research opportunities that will help make treatment safer when it comes to its long-term and late effects on individuals who have leukemia, lymphoma and myeloma.
Toxic side effects of cancer treatments can affect cancer survivors months or years after they complete therapy, sometimes manifesting as chronic conditions, sometimes becoming life threatening, but always unacceptably reducing quality of life.
This initiative seeks to find the biological mechanisms that cause late effects and to develop and test measures to prevent or at least significantly reduce toxicities.
Kevin C. Oeffinger, MD, Director of the Adult Long-Term Follow-Up Program at Memorial Sloan-Kettering Cancer Center leads the initiative.
The Quality of Life Research Initiative's goal is to make current therapies less harmful without sacrificing effectiveness, thus making a difference in patients' lives. We invite you to submit a request for proposal for a Quality of Life Research Initiative opportunity. Please e-mail firstname.lastname@example.org for a more detailed description of the initiative.
Effective Award Year 2013
The Quality of Life Research Initiative is a subcategory of the Career Development and Translational Research grant programs. You must apply to the initiative through one of these two programs.
As much as $5 million over the next five years in projects that successfully compete for funding through our Career Development Program and Translational Research Program.
How to Apply
You must apply through our Career Development Program or Translational Research Program. When you submit your full application, specify that you are applying for a Quality of Life Research Initiative. See those sections for application instructions.
For More Information
Director of Research Administration
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave., Suite 310
White Plains, NY 10605
Phone: (914) 821-8290
Fax: (914) 821-3290